Articles From: Imperial Announces Normal Course Issuer Bid to Imprimis Pharmaceuticals to Host its Third Quarter 2014 Financial Report Conference Call and Webcast on November 12, 2014


http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0973248001&sourceType=1 http://media3.marketwire.com/logos/20121102-iiinew.jpg VANCOUVER, BRITISH COLUMBIA --
Sign-up for Imperial Announces Normal Course Issuer Bid investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0966234001&sourceType=1 http://media3.marketwire.com/logos/20121102-iiinew.jpg VANCOUVER, BRITISH COLUMBIA --
Sign-up for Imperial Completes $115 Million Non-Brokered Private Placement of Convertible Debentures investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0963186001&sourceType=1 http://media3.marketwire.com/logos/20121102-iiinew.jpg VANCOUVER, BRITISH COLUMBIA --
Sign-up for Imperial Earnings Announcement Conference Call Set for August 18, 2014 investment picks
Imperial Holdings, Inc. (NYSE: IFT) announced today that its Board of Directors has adopted a by-law that requires a shareholder, before filing a lawsuit against the company, its board of directors or its officers, to obtain consents of shareholders beneficially owning at least three (3) percent of Imperial’s common shares.
Sign-up for Imperial Holdings Adopts By-law Regarding Claims by Shareholders investment picks
Imperial Holdings, Inc. (NYSE: IFT) ("Imperial"), a specialty finance company with a focus on providing liquidity solutions to owners of illiquid financial assets, announced today it has entered into an agreement to sell up to $100 million in senior secured notes to an affiliate of Indaba Capital Management, L.P. (“Indaba”), one of Imperial’s largest shareholders.
Sign-up for Imperial Holdings Closes Facility for up to $100 Million with Indaba Capital Management investment picks
Imperial Holdings, Inc. (NYSE: IFT), a specialty finance company with a focus on providing liquidity solutions to owners of illiquid financial assets, has become a member of the European Life Settlement Association (ELSA), an organization dedicated to setting standards and promoting best practices for the European life settlement industry.
Sign-up for Imperial Holdings Joins European Life Settlement Association investment picks
Imperial Holdings, Inc. (NYSE: IFT) ("Imperial"), a specialty finance company with a focus on providing liquidity solutions to owners of illiquid financial assets, announced today it has signed and moved into an 11,000 square foot lease negotiated by CBRE at MetLife’s The Plaza in Boca Raton.
Sign-up for Imperial Holdings Moves into New Corporate Offices investment picks
Imperial Holdings, Inc. (NYSE: IFT) ("Imperial" or the "Company"), a specialty finance company with a focus on providing liquidity solutions to owners of illiquid financial assets, announced today its financial results for the three and nine month periods ended September 30, 2014.
Sign-up for Imperial Holdings, Inc. Announces Third Quarter 2014 Results investment picks
Imperial Holdings, Inc. (NYSE: IFT) (“Imperial”) announced today that it will host a conference call on Monday, November 10, 2014 at 5:00 p.m. ET to discuss the Company’s third quarter 2014 financial results.
Sign-up for Imperial Holdings, Inc. Announces Third Quarter 2014 Results Conference Call investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0974424001&sourceType=1 http://media3.marketwire.com/logos/20121102-iiinew.jpg VANCOUVER, BRITISH COLUMBIA --
Sign-up for Imperial Metals Corporation: Mount Polley Remediation Update investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0962975001&sourceType=1 http://media3.marketwire.com/logos/20121102-iiinew.jpg VANCOUVER, BRITISH COLUMBIA --
Sign-up for Imperial Reports 2014 Second Quarter Financial Results and Financing investment picks
http://media.marketwire.com/attachments/201402/226720_Aras_Logo_3003.jpg http://media.marketwire.com/attachments/201409/277952_itg_logo.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1146331&ProfileId=051205&sourceType=1 ANDOVER, MA and MUNICH, GERMANY --
Sign-up for Imperial Tobacco Group Selects Aras as Enterprise PLM Backbone investment picks
Imperva , Inc. (NYSE: IMPV), pioneering the third pillar of enterprise security with a new layer of protection designed specifically for physical and virtual data centers, today announced financial results for the third quarter ended September 30, 2014.
Sign-up for Imperva Announces Third Quarter 2014 Financial Results investment picks
Imperva, Inc. (NYSE: IMPV), pioneering the third pillar of enterprise security with a new layer of protection designed specifically for physical and virtual data centers, today announced that its board of directors has appointed Anthony J.
Sign-up for Imperva Appoints Anthony J. Bettencourt As New President and CEO investment picks
Imperva, Inc. (NYSE: IMPV), pioneering the third pillar of enterprise security with a new layer of protection designed specifically for physical and virtual data centers, today announced that Kim DeCarlis has joined the company as Chief Marketing Officer (CMO). DeCarlis reports directly to Imperva President and CEO, Anthony Bettencourt, and has global responsibility across the marketing spectrum, including corporate marketing, communications, demand generation, product marketing and marketing operations.
Sign-up for Imperva Appoints Kim DeCarlis Chief Marketing Officer investment picks
Imperva, Inc. (NYSE: IMPV), pioneering the third pillar of enterprise security with a new layer of protection designed specifically for physical and virtual data centers, today announced the appointment of Michael D.
Sign-up for Imperva Names Mike Mooney to New Role of Chief Revenue Officer investment picks
Imperva , Inc. (NYSE: IMPV), pioneering the third pillar of enterprise security with a new layer of protection designed specifically for physical and virtual data centers, today announced scheduled participation at the Deutsche Bank Technology Conference in Las Vegas, NV.
Sign-up for Imperva to Present at the Deutsche Bank Technology Conference investment picks
Imperva , Inc. (NYSE: IMPV), pioneering the third pillar of enterprise security with a new layer of protection designed specifically for physical and virtual data centers, today announced scheduled participation at the following upcoming investor conferences: A live webcast, as well as the replay, of these presentations will be accessible from the investors page of Imperva’s website at www.imperva.com .
Sign-up for Imperva to Present at Upcoming Investor Conferences investment picks
2012/12/10
If you're looking to establish a sane, sustainable withdrawal plan, then follow these tips.
Sign-up for Implementing a Total-Return Approach to Retirement Income investment picks
2014/01/30
If you're looking to establish a sane, sustainable withdrawal plan, then follow these tips.
Sign-up for Implementing a Total-Return Approach to Retirement Income investment picks
In December, Royce Focus Trust’s Board of Directors will meet to consider approving a new Investment Advisory Agreement for Royce Focus Trust (Nasdaq: FUND) with Sprott Asset Management, a Toronto-based alternative asset manager.
Sign-up for Important Information About Royce Focus Trust (Nasdaq: FUND) investment picks
2014/9/18
Important Safety Notice: Recall of Everyday Essentials™ Glass Mugs Canada NewsWire BRAMPTON, ON , Sept.
Sign-up for Important Safety Notice: Recall of Everyday Essentials™ Glass Mugs investment picks
2014/10/24
Important Safety Notice: Voluntary Recall of President's Choice® Organics Primavera pasta sauce Canada NewsWire BRAMPTON, ON , Oct.
Sign-up for Important Safety Notice: Voluntary Recall of President's Choice® Organics Primavera pasta sauce investment picks
Patented formulation of alkalized lidocaine and heparin has been prescribed as a compounded drug for individual patients in different dosages in thousands of insurance reimbursed bladder instillation treatments for interstitial cystitis and painful bladder syndrome (IC/PBS) Formulation to form the cornerstone of the Imprimis Defeat IC™ physician and patient education campaign, which is expected to launch in early 2015 SAN DIEGO , Oct.
Sign-up for Imprimis Pharmaceuticals Enters into License Agreement for Patented Urology Formulation investment picks
Dropless cataract surgery created a "buzz" and was a "hot topic" at this year's AAO meeting SAN DIEGO , Oct.
Sign-up for Imprimis Pharmaceuticals Reports on Positive Clinical Findings Presented at the American Academy of Ophthalmology (AAO) Annual Meeting investment picks
Agreement represents the first distributor relationship outside the mainland United States for the company's ophthalmic formulations, which are now available by prescription in 36 states and US territories SAN DIEGO , Nov.
Sign-up for Imprimis Pharmaceuticals Signs Distribution Agreement to Bring Go Dropless™ Proprietary Formulations to Ophthalmologists in Puerto Rico investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Imperial Announces Normal Course Issuer Bid to Imprimis Pharmaceuticals to Host its Third Quarter 2014 Financial Report Conference Call and Webcast on November 12, 2014
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent